110 related articles for article (PubMed ID: 29095656)
1. Fabrication of Eudragit polymeric nanoparticles using ultrasonic nebulization method for enhanced oral absorption of megestrol acetate.
Seo YD; Jin SE; Kim D; Lee DH; Yang SG
Pharm Dev Technol; 2018 Apr; 23(4):407-413. PubMed ID: 29095656
[TBL] [Abstract][Full Text] [Related]
2. Nanomemulsion of megestrol acetate for improved oral bioavailability and reduced food effect.
Li Y; Song CK; Kim MK; Lim H; Shen Q; Lee DH; Yang SG
Arch Pharm Res; 2015 Oct; 38(10):1850-6. PubMed ID: 25893430
[TBL] [Abstract][Full Text] [Related]
3. Development of megestrol acetate solid dispersion nanoparticles for enhanced oral delivery by using a supercritical antisolvent process.
Ha ES; Kim JS; Baek IH; Yoo JW; Jung Y; Moon HR; Kim MS
Drug Des Devel Ther; 2015; 9():4269-77. PubMed ID: 26345723
[TBL] [Abstract][Full Text] [Related]
4. Solid dispersion formulations of megestrol acetate with copovidone for enhanced dissolution and oral bioavailability.
Hong SW; Lee BS; Park SJ; Jeon HR; Moon KY; Kang MH; Park SH; Choi SU; Song WH; Lee J; Choi YW
Arch Pharm Res; 2011 Jan; 34(1):127-35. PubMed ID: 21468924
[TBL] [Abstract][Full Text] [Related]
5. Megestrol acetate NCD oral suspension -- Par Pharmaceutical: megestrol acetate nanocrystal dispersion oral suspension, PAR 100.2, PAR-100.2.
Drugs R D; 2007; 8(4):251-4. PubMed ID: 17596111
[TBL] [Abstract][Full Text] [Related]
6. Novel nanocrystal formulation of megestrol acetate has improved bioavailability compared with the conventional micronized formulation in the fasting state.
Jang K; Yoon S; Kim SE; Cho JY; Yoon SH; Lim KS; Yu KS; Jang IJ; Lee H
Drug Des Devel Ther; 2014; 8():851-8. PubMed ID: 25028536
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Assessment of Food Effect on the Pharmacokinetics of Nano-Crystallized Megestrol Acetate.
Guk J; Son H; Chae DW; Park K
Basic Clin Pharmacol Toxicol; 2017 Mar; 120(3):270-277. PubMed ID: 27639080
[TBL] [Abstract][Full Text] [Related]
8. Food effect on the bioavailability of two distinct formulations of megestrol acetate oral suspension.
Deschamps B; Musaji N; Gillespie JA
Int J Nanomedicine; 2009; 4():185-92. PubMed ID: 19774117
[TBL] [Abstract][Full Text] [Related]
9. Megestrol acetate NCD oral suspension--Par Pharmaceutical: megestrol acetate nanocrystal dispersion oral suspension, PAR 100.2, PAR-100.2.
Drugs R D; 2007; 8(6):403-6. PubMed ID: 17963432
[TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro/in vivo evaluation of gliclazide loaded Eudragit nanoparticles as a sustained release carriers.
Devarajan PV; Sonavane GS
Drug Dev Ind Pharm; 2007 Feb; 33(2):101-11. PubMed ID: 17454041
[TBL] [Abstract][Full Text] [Related]
11. The science of megestrol acetate delivery: potential to improve outcomes in cachexia.
Femia RA; Goyette RE
BioDrugs; 2005; 19(3):179-87. PubMed ID: 15984902
[TBL] [Abstract][Full Text] [Related]
12. Nanonization of megestrol acetate by laser fragmentation in aqueous milieu.
Sylvestre JP; Tang MC; Furtos A; Leclair G; Meunier M; Leroux JC
J Control Release; 2011 Feb; 149(3):273-80. PubMed ID: 21047539
[TBL] [Abstract][Full Text] [Related]
13. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
14. Eudragit® L100-coated mannosylated chitosan nanoparticles for oral protein vaccine delivery.
Xu B; Zhang W; Chen Y; Xu Y; Wang B; Zong L
Int J Biol Macromol; 2018 Jul; 113():534-542. PubMed ID: 29408613
[TBL] [Abstract][Full Text] [Related]
15. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
16. Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment.
Tang J; Xu N; Ji H; Liu H; Wang Z; Wu L
Int J Nanomedicine; 2011; 6():2429-35. PubMed ID: 22072878
[TBL] [Abstract][Full Text] [Related]
17. The elucidation of key factors for oral absorption enhancement of nanocrystal formulations: In vitro-in vivo correlation of nanocrystals.
Imono M; Uchiyama H; Yoshida S; Miyazaki S; Tamura N; Tsutsumimoto H; Kadota K; Tozuka Y
Eur J Pharm Biopharm; 2020 Jan; 146():84-92. PubMed ID: 31816392
[TBL] [Abstract][Full Text] [Related]
18. Improved bioavailability of a micronized megestrol acetate tablet formulation in humans.
Farinha A; Bica A; Tavares P
Drug Dev Ind Pharm; 2000 May; 26(5):567-70. PubMed ID: 10789071
[TBL] [Abstract][Full Text] [Related]
19. Hydrophilic and Functionalized Nanographene Oxide Incorporated Faster Dissolving Megestrol Acetate.
Islam MS; Renner F; Foster K; Oderinde MS; Stefanski K; Mitra S
Molecules; 2021 Mar; 26(7):. PubMed ID: 33807401
[TBL] [Abstract][Full Text] [Related]
20. New Biopolymer Nanoparticles Improve the Solubility of Lipophilic Megestrol Acetate.
Lachowicz M; Kołodziejczyk M; Lukosek M; Kosno J; Olszewska P; Szyma Nski P
Molecules; 2016 Feb; 21(2):. PubMed ID: 26861275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
